Shuhua Breast Tumor Research Center
Shuhua Breast Tumor Research Center

The Shuhua Breast Cancer Research Center operates in collaboration with the Guangdong Provincial Key Laboratory of Malignant Tumor Gene Regulation and Targeted Therapy and the Guangzhou Regenerative Medicine and Health Guangdong Laboratory. It also leverages the largest clinical medical research center in South China dedicated to single-disease (breast cancer) management primarily based on Western medicine. Under the leadership of Academic Leader Professor Song Erwei, the center adheres to the principle of integrating scientific research with clinical practice, focusing on applied basic and translational research. It has successively led major scientific research initiatives, including the National Basic Research Program (973 Program), National Key Research and Development Program projects, National Natural Science Foundation Key Programs and Major Programs, and the NSFC Innovative Research Group Project. Currently, the center has over 50 postdoctoral fellows and master's/doctoral candidates in training. It possesses experimental facilities exceeding 600 square meters across the main campus of Sun Yat-sen Memorial Hospital, the North Campus of Sun Yat-sen University, the East Campus, and the Bio-Island.

Featured Medical Technology

This center conducts systematic and in-depth research focused on the tumor microenvironment and immunotherapy, achieving a series of original academic results. It provides novel insights and strategies for targeting the tumor microenvironment and for immunotherapy against solid tumors, contributing to advancements in the field and exerting significant international influence. Key research findings include:
(1) Discovering new subtypes of various pro-tumorigenic stromal and immune cells within the microenvironment and elucidating their tumor-promoting mechanisms, thereby opening new directions for tumor immunotherapy;
(2) Isolating and identifying receptors for important pro-tumorigenic cytokines, revealing new pathways of immune regulation within the microenvironment;
(3) Discovering novel functions of non-coding RNAs involved in cell signaling within the tumor microenvironment, enriching the understanding of mechanisms within the immunomodulatory signaling network of the microenvironment.
Building upon the above research, the center has proposed the Theory of Tumor Ecology:
(1) Tumor ecology refers to the complex regulatory network of interactions between malignant tumor cells and the various systems within the host's internal environment where they reside.
(2) The tumor ecosystem regulates the occurrence, metastasis, recurrence, and treatment resistance of malignant tumors.
(3) Tumor metastasis and progression are regulated by the local tumor microenvironment, the pre-metastatic niche of distant organs, as well as the systemic immune and neuroendocrine systems.

Scientific Research Results

The research center has achieved substantial outcomes, having published over 200 SCI journal articles as the first completion unit. This includes 12 publications in prestigious academic journals such as Nature, Cell (5 articles), Cancer Cell (3 articles), Nature Immunology, Nature Cell Biology, Science Translational Medicine, and Cell Research, with citations exceeding 10,000 times. Its scientific achievements have been selected twice for the "Top Ten Science and Technology Advances of Chinese Universities" and have received, as the first completion unit, the Second Prize of the National Natural Science Award, the First Prize of the Higher Education Institutions Natural Science Award of the Ministry of Education, and the First Prize of the Guangdong Provincial Science and Technology Award (Natural Science Category). The center holds 2 authorized international invention patents, 8 domestic invention patents, 1 computer software copyright, and 3 utility model patents.